Delcath Systems Announces Second Quarter 2021 Results

Stock Information for ARCA biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ARCA biopharma Inc.

Delcath Systems, Inc. Announces Positive Phase 3 FOCUS Trial Results for Hepzato(TM) in Liver-Dominant Metastatic Ocular Melanoma, Including Initial Survival Data Analysis
Delcath Systems Provides Speaker List for Dec 2, 2021 Investor Update Meeting
Delcath Systems Announces Third Quarter 2021 Results
Delcath Systems to Participate in the Canaccord Virtual MedTech, Diagnostics and Digital Health & Services Forum on November 18, 2021
Delcath Systems to Hold Investor Update on Focus Trial Data and Future Development Plans on December 2, 2021
Delcath Systems Schedules Conference Call to Report 2021 Third Quarter Financial Results
Delcath Systems to Present at Upcoming Virtual Investor Conferences
Delcath Systems Secures Up to a $20.0 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.